Guardant Health (GH) Other financing activities (2017 - 2026)

Guardant Health has reported Other financing activities for 10 years, with the latest figure at $26.1 million in Q2 2026.

• Quarterly Other financing activities rose 276.92% year-over-year to $26.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $33.1 million (up 171.76% YoY) and the FY2025 annual result came in at $19.2 million, up 64.03% from the prior year.
• Other financing activities improved to $26.1 million in Q2 2026 per GH's latest filing, from -$4.5 million in the prior quarter.
• Over five years, Other financing activities peaked at $26.1 million in Q2 2026 and troughed at -$4.5 million in Q1 2026.
• A 5-year average of $5.1 million and a median of $4.0 million in 2022 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2022 and 2026: Other financing activities surged 408.95% in 2022, then sank 682.81% in 2026.
• Over 5 years, Other financing activities stood at $3.6 million in 2022, then declined by 3.27% to $3.5 million in 2023, then soared by 30.37% to $4.5 million in 2024, then soared by 156.11% to $11.5 million in 2025, then soared by 125.7% to $26.1 million in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $26.1 million, -$4.5 million, and $11.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.